Bayer backs retrofit autonomy as row crop margins collapse
Sabanto closes oversubscribed Series B led by Leaps by Bayer, validating retrofit autonomy as OEM alternative when farm economics force smaller-equipment strategies.
Memento launches $93M bispecific bet against retinal disease standard
Memento Medicines raised $93M to develop MMT-205, a dual-mechanism antibody challenging anti-VEGF monotherapy dominance in nAMD and DME markets worth billions annually.
Anterra Capital raises $100M as generalist VCs abandon agtech
Anterra Capital closed $100M for its third fund targeting $200M, backed by Rabobank, Novo Holdings, and Zoetis, a counter-cyclical bet that AI adoption in agriculture will reward disciplined operators over hype.
Corteva backs crop immunity startup with $10.3M oversubscribed round
Resurrect Bio closes Series A at €8.8M led by Corteva, betting on AI-powered gene editing to reactivate dormant disease resistance and displace chemical pesticides in commercial crop pipelines.
Purdue spinoff gets $174K USDA grant for nitrogen-efficient wheat
Novin AgriTech received federal SBIR funding to validate a tissue culture-free wheat transformation platform, the first genotype-independent NUE trait engineering program at commercial stage.
Carbon Robotics Crosses $100M Revenue on AI Laser-Weeding Platform
Carbon Robotics surpassed $100 million in annual revenue for its fiscal year ending January 31, 2026, making it the first commercial field-robotics agtech company built around herbicide elimination to reach nine-figure revenue.